Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer

The first-line chemotherapy drug adriamycin (ADM) is widely used for the treatment of breast cancer, but the acquired drug resistance and the normal tissue toxicity remain clinical challenges. Alteronol has been reported to exert wide-ranging anti-tumor activity. In this study, we firstly examined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Boxue, Ye, Lei, Gong, Jianwei, Ren, Huanhuan, Ding, Yangfang, Chen, Xiaoyu, Liu, Xiaona, Lu, Peng, Wei, Fei, Xu, Wenjuan, Zheng, Qiusheng, Li, Defang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455060/
https://www.ncbi.nlm.nih.gov/pubmed/31001113
http://dx.doi.org/10.3389/fphar.2019.00285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455060/
https://www.ncbi.nlm.nih.gov/pubmed/31001113
http://dx.doi.org/10.3389/fphar.2019.00285

Ejemplares similares